Skip to main content
Edwards Lifesciences Logo

The CLASP IID/IIF Trial for Mitral Regurgitation

Patient information

dad and two kids
dad and two kids
dad and two kids

References

  1. Mitral Valve Regurgitation. Mayo Clinic. Updated Feb 08, 2022. Accessed May 26, 2023. https://mayoclinic.org/diseases-conditions/mitral-valve-regurgitation/symptoms-causes/syc-20350178.
  2. Edwards PASCAL CLASP IID/IIF Clinical Trial Protocol Rev E.1.
  3. Mitral Valve Disease: Percutaneous Interventions. Cleveland Clinic. Updated May 3, 2019. Accessed May 26, 2023. https://my.clevelandclinic.org/health/treatments/17239-mitral-valve-disease-percutaneous-interventions.
  4. Clinical trials: what patients need to know. US Food and Drug Administration. Updated November 6, 2014. Accessed May 26, 2023. https://www.fda.gov/patients/clinical-trials-what-patients-need-know.
  5. Inside Clinical Trials: Testing Products in People. US Food and Drug Administration. Updated November 6, 2014. Accessed May 26, 2023. https://www.fda.gov/drugs/drug-information-consumers/inside-clinical-trials-testing-medical-products-people.

Important safety information

Caution - Investigational device. Limited by Federal (or United States) law to investigational use. This device is not available for marketing or commercial sale for the treatment of functional mitral regurgitation in the United States. See Instructions for Use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.

Edwards Lifesciences is the sponsor of the CLASP IID/IIF trial.

Edwards, Edwards Lifesciences, the stylized E logo, and PASCAL are trademarks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners

© 2023 Edwards Lifesciences Corporation. All rights reserved. PP--US-5277 v2.0